Not checked for notices yet.

An analysis of 45 large-scale wastewater sites in England to estimate SARS-CoV-2 community prevalence

Mario Morvan, Anna Lo Jacomo, Celia Souque and 13 more

Nature Communications · 2022

doi:10.1038/s41467-022-31753-y

References 58

1.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
2.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
3.
The Characterization of Feces and Urine: A Review of the Literature to Inform Advanced Treatment Technology · 2015
No notice
4.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
5.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
6.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
7.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
8.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
9.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
10.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
11.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
12.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
13.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
14.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
15.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
16.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
17.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
18.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
19.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
20.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
21.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
22.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
23.
SARS-CoV-2 Titers in Wastewater Are Higher than Expected from Clinically Confirmed Cases · 2020
No notice
24.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
25.
Making waves: Wastewater-based epidemiology for COVID-19 – approaches and challenges for surveillance and prediction · 2020
No notice
26.
Substantial underestimation of SARS-CoV-2 infection in the United States · 2020
No notice
27.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
28.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
29.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
30.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
31.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
32.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
33.
Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study · 2021
No notice
34.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
35.
Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey · 2021
No notice
36.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
37.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
38.
Quantifying asymptomatic infection and transmission of COVID-19 in New York City using observed cases, serology, and testing capacity · 2021
No notice
39.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
40.
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England · 2021
No notice

All 58 references

Cited by papers we hold 1

Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population · 2023
Corrected

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.